Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A new gene mutation caused a man's rare skin condition, Schöpf-Schulz-Passarge syndrome.

These medications for BPH have known risks and may have new side effects.

TPA is about 50 times more effective at promoting tumors than MZ.

A semi-automated system can effectively help choose emulsion ingredients, simplifying the creation of medicinal and cosmetic products.

Targeting CD169+ skin macrophages may help treat psoriasis.

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

Older patients sticking to their prostate medication saw lasting health benefits.

PICAT is a reliable tool for assessing dermatology residents' skills in PRP procedures for hair loss.

These medications for BPH have known risks and may have new side effects.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

PRS injections can improve knee function and reduce pain for up to a year.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

SMAD4 is crucial for muscle repair in young adults but not in aged mice.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

The CTLA-4 gene polymorphism does not affect polycystic ovarian syndrome.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

Serotype 4 of Ureaplasma showed the highest pathogenicity in female mice.

Alpha-melanocyte-stimulating hormone helps manage skin inflammation and protect against UV damage.

Brodalumab is more effective than ustekinumab in treating psoriasis.